Clinical Trials Directory

Trials / Conditions / Stage III Pancreatic Cancer AJCC v6 and v7

Stage III Pancreatic Cancer AJCC v6 and v7

15 registered clinical trials studyying Stage III Pancreatic Cancer AJCC v6 and v7 — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069
Alliance for Clinical Trials in Oncology—
Active Not RecruitingGuadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder C
NCT03257761
University of Southern CaliforniaPhase 1
CompletedSelumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R
NCT03040986
National Cancer Institute (NCI)Phase 2
Active Not RecruitingHypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Ca
NCT03073785
University of NebraskaPhase 2
Active Not RecruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
NCT02498613
National Cancer Institute (NCI)Phase 2
Active Not RecruitingRopidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
NCT02381561
National Cancer Institute (NCI)Phase 1
Active Not RecruitingGemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, an
NCT02336087
City of Hope Medical CenterPhase 1
CompletedNab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With
NCT02394535
M.D. Anderson Cancer CenterPhase 1
CompletedAfatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Can
NCT02451553
University of WashingtonPhase 1
CompletedPaclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhi
NCT02194829
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedDinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surg
NCT01783171
National Cancer Institute (NCI)Phase 1
CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfun
NCT01638533
National Cancer Institute (NCI)Phase 1
Active Not RecruitingGemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer
NCT01660971
National Cancer Institute (NCI)Phase 1
Active Not RecruitingVaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
NCT00669734
National Cancer Institute (NCI)Phase 1
Completed3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Sur
NCT00288093
National Cancer Institute (NCI)Phase 1